Cargando…
Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor
Melanoma is a deadly disease at late metastatic stage, and early diagnosis and accurate staging remain the key aspects for managing melanoma. The melanocortin 1 receptor (MC1 R) is overexpressed in primary and metastatic melanomas, and its endogenous ligand, the α-melanocyte-stimulating hormone (αMS...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714078/ https://www.ncbi.nlm.nih.gov/pubmed/29182034 http://dx.doi.org/10.1177/1536012117737919 |